|
標題および責任表示
|
Kinase inhibitor drugs / edited by Rongshi Li, Jeffrey A. Stafford
|
|
出版・頒布事項
|
Hoboken, N.J. : Wiley , c2009
|
|
形態事項
|
xv, 510 p., [16] p. of plates : ill. (some col.) ; 25 cm
|
|
巻号情報
|
| 巻次等 |
: (cloth) |
| ISBN |
9780470278291 |
|
|
書誌構造リンク
|
Wiley series in drug discovery and development / Binghe Wang, series editor <BB12395455>//a
|
|
内容著作注記
|
Discovery and development of sunitinib (SU11248) : a multitarget tyrosine kinase inhibitor of tumor growth, survival, and angiogenesis / Connie L. Sun, James G. Christensen, and Gerald McMahon
|
|
内容著作注記
|
Tykerb discovery : a dual EGFR and ERBB2 tyrosine kinase inhibitor / Karen Lackey and G. Stuart Cockerill
|
|
内容著作注記
|
Discovery of pazopanib : a pan vascular endothelial growth factor kinase inhibitor / Philip A. Harris and Jeffrey A. Stafford
|
|
内容著作注記
|
Road to ABT-869 : a multitargeted receptor tyrosine kinase inhibitor / Michael Michaelides and Daniel H. Albert
|
|
内容著作注記
|
Discovery of motesanib / Andrew S. Tasker and Vinod F. Patel
|
|
内容著作注記
|
Discovery of brivanib alaninate : a dual vascular endothelial growth factor and fibroblast growth factor receptor inhibitor / Rajeev S. Bhide and Joseph Fargnoli
|
|
内容著作注記
|
Structure-based design and characterization of axitinib / Robert S. Kania
|
|
内容著作注記
|
Road to PD0325901 and beyond : the MEK inhibitor quest / Judith S. Sebolt-Leopold and Alexander J. Bridges
|
|
内容著作注記
|
Discovery of allosteric MEK inhibitors / Eli Wallace and James F. Blake
|
|
内容著作注記
|
Discovery of MK-0457 (VX-680) / Julian M.C. Golec
|
|
内容著作注記
|
Discovery of PHA-739358 / Daniele Fancelli and Jürgen Moll
|
|
内容著作注記
|
Discovery of AZD1152 : a selective inhibitor of aurora-B kinase with potent antitumor activity / Kevin M. Foote and Andrew A. Mortlock
|
|
内容著作注記
|
Case study of aurora-A inhibitor MLN8054 / Christopher F. Claiborne and Mark G. Manfredi
|
|
内容著作注記
|
Discovery of GSK461364 : a polo-like kinase 1 inhibitor for the treatment of cancer / Kevin W. Kuntz and Kyle A. Emmitte
|
|
内容著作注記
|
Pharmacogenomics of dasatinib (Sprycel TM) / Fei Huang and Edwin A. Clark
|
|
内容著作注記
|
Practical use of computational chemistry in kinase drug discovery / James M. Veal
|
|
内容著作注記
|
Approaches to kinase homology modeling : successes and considerations for the structural kinome / Victoria A. Feher and J. David Lawson
|
|
内容著作注記
|
Fragment-based drug discovery of kinase inhibitors / Daniel A. Erlanson
|
|
内容著作注記
|
Protein kinase structural biology : methods and strategies for targeted drug discovery / Clifford D. Mol, Kengo Okada, and David J. Hosfield
|
|
注記
|
Includes bibliographical references and index
|
|
学情ID
|
BB04590224
|
|
本文言語コード
|
英語
|
|
著者標目リンク
|
Li, Rongshi <>
|
|
著者標目リンク
|
Stafford, Jeffrey A. <>
|
|
分類標目
|
LCC:RM666.E548
|
|
分類標目
|
NLM:2009 M-181
|
|
分類標目
|
NLM:QZ 267
|
|
分類標目
|
DC22:615/.798
|
|
件名標目等
|
Protein kinases -- Inhibitors -- Therapeutic use
|
|
件名標目等
|
Antineoplastic agents
|
|
件名標目等
|
Neoplasms -- drug therapy
|
|
件名標目等
|
Protein Kinase Inhibitors -- therapeutic use
|
|
件名標目等
|
Antineoplastic Agents -- therapeutic use
|
|
件名標目等
|
Drug Discovery
|
|
件名標目等
|
Protein Kinase Inhibitors -- pharmacology
|
|
件名標目等
|
Protein Kinases -- metabolism
|
目録検索 ▼
Webサービス ▼
